APPROACH UNDER REVIEW: `rag`

SCENARIO ID: scenario_24
APP DESCRIPTION: VoiceMind is a hospital-waiting-room kiosk that records a 60-second voice sample, runs an ML model that flags depression risk, and notifies the front desk to suggest an appointment. Designed for primary-care clinics. EU.

DEVELOPER PERSONA: AI researcher founder, technically strong, regulation-fluent on paper.

EXPECTED HERA DIMENSIONS (gold standard): P1.D2, P1.D4, P2.D1, P2.D3, P2.D6, P3.D1, P3.D5, P4.D3, P5.D1, P5.D2, P5.D4, P6.D1, P6.D3, P7.D1, P7.D3, P7.D5

TRANSCRIPT:
### USER
VoiceMind is a hospital-waiting-room kiosk that records a 60-second voice sample, runs an ML model that flags depression risk, and notifies the front desk to suggest an appointment. Designed for primary-care clinics. EU.

### ASSISTANT
Does VoiceMind explicitly inform users that their voice sample is being processed by an AI system and that their data may be used for depression risk assessment? [card_ai_act_transparency · p.0]

### USER
I'm clear on this one: we're treating VoiceMind as Class IIa SaMD under MDR Rule 11 because it's software informing a clinical decision, and CE marking is in progress. That classification work is the part I'm most confident about.

### ASSISTANT
What specific clinical decisions does VoiceMind aim to support, and how does the potential for error (e.g., false positives/negatives) align with the "moderate" harm threshold under MDR Rule 11(a)? [mdr_class_iia · p.0]

### USER
I'm regulation-fluent on the MDR side, but I'll concede I've done less concrete work on the EU AI Act. A depression-risk classifier for healthcare almost certainly lands in the Annex III high-risk bucket, and I haven't completed a formal AI Act classification or the conformity work that goes with it — I've been treating MDR as the primary lens.

### ASSISTANT
Given your acknowledgment that the depression-risk classifier likely falls under Annex III high-risk AI, what specific measures have you considered to ensure **human oversight** and **accuracy, robustness, and cybersecurity** as required by **Art. 14** and **Art. 15** of the EU AI Act? [ai_act_high_risk · p.0]

### USER
The classifier produces a risk score but it's essentially a black box to the end users — a clinician can't currently see why a given patient was flagged. We don't yet surface the driving voice features like pitch variability or speech rate, so there's no explanation a doctor could sanity-check the flag against.

### ASSISTANT
This lack of explainability raises significant risks under **[P2.D11] AI transparency and explainability** and **[P3.D6] Clinical safety and human oversight**. Under the EU AI Act, high-risk AI systems must be **"robust, accurate, and secure"** (Art. 15) and **"transparent"** (Art. 50), including providing **meaningful information** to users and stakeholders. 

To mitigate these risks, you must implement **explanation mechanisms** for clinicians, such as **feature attribution** or **model interpretability tools**, to allow them to **sanity-check** the AI's decisions. This is also required under **[P3.D12] Clinical decision support and transparency**. 

Consider integrating **model-agnostic explainability tools** (e.g., SHAP, LIME) to surface key voice features like pitch variability or speech rate, and ensure that these explanations are **clinically relevant** and **actionable**. This will align with **Art. 14(2)** of the EU AI Act, which mandates **human oversight** and **transparency** for high-risk AI systems.

### USER
We validated and operate within a limited language scope, and I'll admit we haven't separately validated performance across the different languages and dialects you'd actually hit across the EU. The kiosk doesn't currently detect when a speaker is out of our validated language scope and refuse to score, so cross-population robustness is unproven.

### ASSISTANT
This raises a critical risk under **[P2.D10] Data diversity and representativeness** and **[P3.D5] Algorithmic fairness and robustness**. Under the EU AI Act, high-risk AI systems must be **"robust and accurate"** (Art. 15), which includes **ensuring the system performs reliably across the population it is intended to serve**. 

Since your system does **not currently detect out-of-scope languages** and **does not refuse to score**, you risk **biased outcomes** and **non-compliance** with the **EU AI Act’s robustness requirements** (Art. 15(2)). Additionally, under the **GDPR**, failing to ensure **data representativeness** could lead to **violations of Art. 22** regarding automated decision-making and **data subject rights**.

To mitigate these risks, you must:  
1. **Implement language detection** to **refuse scoring** when the input is outside the validated language scope, as required by **[P3.D1] System integrity and error handling**.  
2. **Conduct separate performance validation** across **EU languages and dialects** to ensure **cross-population robustness**, as mandated by **[P2.D10]** and the **EU AI Act’s robustness requirements** (Art. 15(2)).  
3. **Document and disclose** the **language limitations** to users, in line with **[P2.D11] AI transparency and explainability** and **[P3.D12] Clinical decision support and transparency**.  

This will ensure compliance with **[P2.D10]**, **[P3.D5]**, and **[P3.D1]**, and align with the **EU AI Act** and **GDPR**.

### USER
Our headline number is AUROC 0.82 on N=400 against PHQ-9, but I'll concede that's an aggregate and we haven't run subgroup evaluation by accent, age, sex, or dialect. Wav2Vec-based speech models are known to be sensitive to exactly those factors, so the overall number almost certainly hides worse performance for some groups, and we don't currently refuse to score voices outside our validated profile.

### ASSISTANT
This exposes a significant risk under **[P2.D10] Data diversity and representativeness** and **[P3.D5] Algorithmic fairness and robustness**. The **AUROC of 0.82** is **not sufficient** for high-risk AI systems under the **EU AI Act**, as it does not account for **subgroup disparities** or **performance variability** across **demographic and linguistic factors** like **accent, age, sex, and dialect**. This lack of **subgroup evaluation** violates the **EU AI Act’s robustness and fairness requirements** (Art. 15(2)) and could lead to **biased outcomes** and **non-compliance** with **[P3.D5]** and **[P2.D10]**.

To mitigate these risks, you must:  
1. **Conduct subgroup analysis** by **accent, age, sex, and dialect** to identify **performance gaps** and ensure **fairness** across all groups, as required by **[P3.D5]** and **[P2.D10]**.  
2. **Implement mechanisms to detect and refuse scoring** for voices outside your **validated profile**, as mandated by **[P3.D1] System integrity and error handling**.  
3. **Document and disclose** the **limitations of your model’s performance** and **language/demographic coverage**, in line with **[P2.D11] AI transparency and explainability** and **[P3.D12] Clinical decision support and transparency**.  

This will ensure compliance with **[P2.D10]**, **[P3.D5]**, and **[P3.D1]**, and align with the **EU AI Act** and **GDPR**.

### USER
Strictly, the only data we need for the function is the 60-second sample, the resulting risk score, and the front-desk action. I'd argue we're fairly lean, but retaining raw audio for 7 days and embeddings for a full year goes beyond the bare minimum needed to just produce and act on the score, and we haven't pressure-tested those retention windows against data minimization.

### ASSISTANT
This raises a critical risk under **[P2.D8] Data minimization and retention** and **[P3.D4] Data security and privacy by design**. Retaining **raw audio for 7 days** and **embeddings for a full year** exceeds the **data minimization** requirement under the **EU AI Act** (Art. 5(1)(c)) and **GDPR** (Art. 5(1)(c)), which mandates that data be **collected and retained only for as long as necessary** for the purposes for which it was processed.

The lack of **pressure-testing** these **retention periods** against **data minimization** principles increases the risk of **unlawful data retention**, **exposure to data breaches**, and **non-compliance** with **[P2.D8]** and **[P3.D4]**. Under the **EU AI Act**, high-risk AI systems must be **"secure"** (Art. 15(1)), which includes **protecting data from unauthorized access, processing, or retention**.

To mitigate these risks, you must:  
1. **Review and justify** the **retention periods** for **raw audio** and **embeddings** against the **specific purpose** of generating the **risk score** and **front-desk action**, as required by **[P2.D8]** and **[P3.D4]**.  
2. **Implement a data retention policy** that **aligns with the minimum necessary** for the system’s function, and **pressure-test** these periods against **data minimization** principles.  
3. **Ensure that raw audio and embeddings are securely deleted** once they are no longer needed, and **document this process** to demonstrate compliance with **[P2.D8]** and **[P3.D4]**.  

This will ensure compliance with **[P2.D8]**, **[P3.D4]**, and **[P3.D1]**, and align with the **EU AI Act** and **GDPR**.

### USER
Audio kept 7 days for incident review; embeddings retained 1 year.

### ASSISTANT
This retention policy introduces significant risks under **[P2.D8] Data minimization and retention** and **[P3.D4] Data security and privacy by design]**. Retaining **raw audio for 7 days** and **embeddings for 1 year** exceeds the **minimum necessary** for the system’s function (generating a risk score and triggering front-desk action), and without **pressure-testing** these periods against **data minimization** principles, you risk **non-compliance** with the **EU AI Act** (Art. 5(1)(c)) and **GDPR** (Art. 5(1)(c)).

Under the **EU AI Act**, high-risk AI systems must be **"secure"** (Art. 15(1)), which includes **protecting data from unauthorized access, processing, or retention**. The **7-day retention of raw audio** is **not justified** unless there is a **clear, documented need** for incident review, and the **1-year retention of embeddings** is **excessive** without a **proportionality assessment**.

To mitigate these risks, you must:  
1. **Justify the 7-day retention of raw audio** as **necessary for incident review**, and ensure it is **proportionate to the risk** (Art. 5(1)(c) GDPR, Art. 15(1) EU AI Act).  
2. **Conduct a data minimization assessment** for the **1-year retention of embeddings**, and **justify** it as **necessary for the system’s function**, or **reduce the retention period** to the **minimum required** (Art. 5(1)(c) GDPR, Art. 15(1) EU AI Act).  
3. **Implement secure deletion mechanisms** for both raw audio and embeddings once they are no longer needed, and **document this process** to demonstrate compliance with **[P2.D8]** and **[P3.D4]**.  

This will ensure compliance with **[P2.D8]**, **[P3.D4]**, and **[P3.D1]**, and align with the **EU AI Act** and **GDPR**.

### USER
Front-desk access to the flags and the retained embeddings is something we haven't locked down with formal role-based controls or audit logging. I can't yet tell you exactly who at a clinic can see historical scores or audio, or how we'd securely delete embeddings on a legal request — that access-governance layer isn't formalized.

### ASSISTANT
This exposes a critical risk under **[P2.D7] Access control and data governance** and **[P3.D4] Data security and privacy by design]**. Without **formal role-based access controls**, **audit logging**, or a **secure deletion process**, you risk **unauthorized access**, **data breaches**, and **non-compliance** with the **EU AI Act** (Art. 15(1)) and **GDPR** (Art. 30, Art. 30(3)).

The **lack of access governance** means you cannot **determine who can view historical scores, audio, or embeddings**, which violates the **principle of data minimization** and **privacy by design** (Art. 25 GDPR). Additionally, the **absence of a secure deletion mechanism** for embeddings on legal requests (e.g., under **Article 17 GDPR**) could lead to **non-compliance** with **data subject rights** and **data minimization**.

To mitigate these risks, you must:  
1. **Implement role-based access controls (RBAC)** to ensure only **authorized personnel** can access **flags, audio, and embeddings**, as required by **[P2.D7]** and **[P3.D4]**.  
2. **Enable audit logging** to track who accessed what data and when, in line with **[P2.D7]** and **[P3.D4]**.  
3. **Formalize a secure deletion process** for embeddings and raw audio on **legal requests**, including **deletion confirmation and documentation**, to comply with **[P2.D8]** and **[P3.D4]**.  
4. **Document and review access policies** regularly to ensure they align with **data minimization**, **privacy by design**, and **compliance requirements** under the **EU AI Act** and **GDPR**.

This will ensure compliance with **[P2.D7]**, **[P2.D8]**, and **[P3.D4]**, and align with the **EU AI Act** and **GDPR**.

### USER
My legal basis is patient consent captured on the kiosk, and I treat this as GDPR Article 9 special-category health data. On paper that's the framing, but given the waiting-room setting I haven't fully stress-tested whether that consent is actually freely given, or whether we should be leaning on a clinical/health-provision basis instead.

### ASSISTANT
This raises a critical risk under **[P2.D2] Lawful basis and purpose limitation** and **[P3.D1] System integrity and error handling]**. Relying solely on **patient consent** for processing **health data** under **Article 9 GDPR** may not be **sufficient** in a **waiting-room setting**, where **consent may not be freely given** due to **coercion, pressure, or lack of alternatives**. The **EU AI Act** (Art. 15(1)) and **GDPR** (Art. 4(11)) require that data processing be **lawful, fair, and transparent**, and that **consent** be **freely given**, **specific**, and **informed**.

In a **clinical or health-provision context**, the **legal basis** for processing **health data** may be more appropriately grounded in **Article 9(2)(g)** GDPR — **processing carried out in the public interest** — or **Article 9(2)(h)** — **processing necessary for the purposes of healthcare**. This is particularly relevant in a **front-desk or waiting-room setting**, where the **processing of health data** is **integral to the delivery of care** and **not merely a convenience**.

To mitigate these risks, you must:  
1. **Assess whether the consent captured on the kiosk is freely given**, **specific**, and **informed**, and **stress-test** this against the **GDPR’s consent requirements** (Art. 4(11), Art. 7(1)).  
2. **Evaluate whether a clinical/health-provision basis** (Article 9(2)(g) or (h) GDPR) is more appropriate for your use case, especially in a **clinical setting** where the **processing of health data** is **integral to care delivery**.  
3. **Document the legal basis for processing** and ensure it is **aligned with the EU AI Act** (Art. 15(1)) and **GDPR** (Art. 9, Art. 4(11)).  
4. **Review and update your data processing policies** to reflect the **contextual and functional requirements** of your system, ensuring **lawfulness**, **fairness**, and **transparency**.

This will ensure compliance with **[P2.D2]**, **[P3.D1]**, and **[P3.D4]**, and align with the **EU AI Act** and **GDPR**.

### USER
I'll be honest that the consent flow is technically clean but contextually weak: the patient signs on the kiosk in the open waiting room, often with a receptionist and a queue right there. I haven't designed a genuinely private 'No, thanks' path, so the refusal option isn't something a patient can take without it being visible to staff and other people waiting.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Report: mHealth Audio Risk Scoring System**  
*Prepared by HERA Risk & Safety Copilot*  

---

### **High Severity Risks**  
**[P2.D2] Lawful basis and purpose limitation**  
- **Risk**: Consent is captured in a **public, non-private setting** (waiting room), which may **not meet GDPR’s ‘freely given’ requirement** (Art. 4(11), Art. 7(1)).  
- **Impact**: Consent may be **coerced or not genuinely informed**, leading to **non-compliance with Article 9 GDPR** and **EU AI Act Art. 15(1)**.  
- **Mitigation**: Transition to a **clinical/health-provision legal basis** (Art. 9(2)(g) or (h) GDPR) or **re-design the consent flow** to ensure **privacy and genuine choice**.  

**[P3.D1] System integrity and error handling**  
- **Risk**: No **private ‘No, thanks’ path** exists, making **refusal visible to staff and others**. This **violates data minimization** (Art. 5(1)(c) GDPR) and **privacy by design** (Art. 25 GDPR).  
- **Impact**: Patients may **feel pressured** to consent, leading to **unlawful processing** of health data.  
- **Mitigation**: Design a **secure, private refusal pathway** with **no visibility to staff or others**, and **document this as part of your data minimization strategy**.  

---

### **Medium Severity Risks**  
**[P2.D7] Access control and data governance**  
- **Risk**: No **formal role-based access controls** or **audit logging** for access to **flags, audio, and embeddings**.  
- **Impact**: Unauthorized access or **data breaches** may occur, violating **GDPR Art. 30** and **EU AI Act Art. 15(1)**.  
- **Mitigation**: Implement **RBAC**, **audit logging**, and **secure deletion mechanisms** for embeddings and audio.  

**[P3.D4] Data security and privacy by design**  
- **Risk**: **No secure deletion process** for embeddings on **legal requests** (e.g., Article 17 GDPR).  
- **Impact**: Non-compliance with **data subject rights** and **data minimization**.  
- **Mitigation**: Formalize a **secure deletion process** with **deletion confirmation and documentation**.  

---

### **Low Severity Risks**  
**[P2.D8] Data retention and deletion**  
- **Risk**: **1-year retention of embeddings** is **excessive** without **proportionality assessment**.  
- **Impact**: Violates **GDPR Art. 5(1)(c)** and **EU AI Act Art. 15(1)**.  
- **Mitigation**: Conduct a **data minimization assessment** and **justify retention period** or **reduce it to minimum necessary**.  

**[P2.D5] Transparency and information**  
- **Risk**: **Lack of clear explanation** of how data is used, stored, and deleted.  
- **Impact**: Violates **GDPR Art. 13–14** and **EU AI Act Art. 15(1)**.  
- **Mitigation**: Provide **clear, concise information** about data processing and **patient rights**.  

---

### **Dimensions Not Covered**  
The following HERA dimensions were not assessed in detail:  
- **[P1.D1] Human-centric design and user experience**  
- **[P1.D3] Ethical and social considerations**  
- **[P1.D4] Accountability and governance**  
- **[P2.D1] Data subject rights and portability**  
- **[P3.D2] System resilience and continuity**  
- **[P3.D3] Interoperability and data sharing**  

---

**Next Steps**:  
- Re-evaluate **legal basis** and **consent flow** for **privacy and freedom of choice**.  
- Implement **secure access controls**, **audit logging**, and **secure deletion mechanisms**.  
- Conduct a **data minimization assessment** for embeddings and **retention period**.  
- Formalize **data processing policies** and **patient rights documentation**.  

Let me know if you’d like a **compliance checklist** or **GDPR/Artificial Intelligence Act alignment roadmap**.

Now produce the JSON judgement object.